Pharming Group NV (PHAR) — Cash Flow Quality Index
Pharming Group NV (PHAR) has a Cash Flow Quality Index of 1.40x as of December 2025. Operating cash flow of $7.39 Million exceeds net income of $5.29 Million, indicating high earnings quality where cash backs reported profits. Explore PHAR cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharming Group NV Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Pharming Group NV across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Pharming Group NV to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Pharming Group NV (2017–2025)
Year-by-year earnings quality comparison for Pharming Group NV. For live market cap and the full company financial profile, see how much is Pharming Group NV worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 17.51x | $50.07 Million | $2.86 Million | ▲ +1068.6% |
| 2022 | 1.50x | $22.46 Million | $14.99 Million | ▼ -8.6% |
| 2021 | 1.64x | $37.84 Million | $23.08 Million | ▼ -13.5% |
| 2020 | 1.90x | $83.63 Million | $44.09 Million | ▲ +33.8% |
| 2019 | 1.42x | $74.15 Million | $52.30 Million | ▲ +33.4% |
| 2018 | 1.06x | $46.19 Million | $43.46 Million | ▼ -39.1% |
| 2017 | 1.74x | $45.84 Million | $26.29 Million | — |